A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
Eli Lilly and Company
Pheast Therapeutics
NiKang Therapeutics, Inc.
Seagen Inc.
Pliant Therapeutics, Inc.
BioNTech SE
Eli Lilly and Company
BioNTech SE
Kivu Bioscience Inc.
University of California, San Francisco
Wake Forest University Health Sciences
MOMA Therapeutics
Kestrel Therapeutics, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
OncoC4, Inc.
Parabilis Medicines, Inc.
Jazz Pharmaceuticals
Compass Therapeutics
Revolution Medicines, Inc.
Bayer
USWM, LLC (dba US WorldMeds)
Fate Therapeutics
Centre hospitalier de l'Université de Montréal (CHUM)
IDEAYA Biosciences
Agenus Inc.
Radiopharm Theranostics, Ltd
858 Therapeutics, Inc.
Radiopharm Theranostics, Ltd
Eisai Inc.
GlaxoSmithKline
SystImmune Inc.
Terremoto Biosciences Inc.
GlaxoSmithKline
Institut Paoli-Calmettes
AstraZeneca
Artios Pharma Ltd
PMV Pharmaceuticals, Inc
Mayo Clinic
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
AstraZeneca
Rutgers, The State University of New Jersey
Qilu Pharmaceutical Co., Ltd.
Sutro Biopharma, Inc.
National Institutes of Health Clinical Center (CC)
Psyence Australia Pty Ltd
Convalife (Shanghai) Co., Ltd.